MolNFT v1 · #128610 · protein
PVHL:ELOB:ELOC in complex with (2S,4R)-1-((S)-2-(1- acetylcyclopropanecarboxamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4- (4-methylthiazol-5-YL)BENZYL)PYRROLIDINE-2-carboxamide (ligand 16)
5NVZ · Elongin-B: “PVHL:ELOB:ELOC in complex with (2S,4R)-1-((S)-2-(1- acetylcyclopropanecarboxamido)-3,3-dimethylbutanoyl)-4-hyd…”. X-ray diffraction, 1 ligand (9BN), 9 pockets (best druggability 0.62). MolNFT v1 #128610 on GenesisL1: 3D…
- PDB
- 5NVZ
- Type
- protein
- Length
- 1,339 residues
- Chains
- 12
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Elongin-B; Elongin-C; Von hippel-lindau disease tumor suppressor
- UniProt
- Q15370, Q15369, P40337
- Ligands
- 9BN
- Pockets
- 9 · best druggability 0.62
Structure
x-ray diffraction · 8 distinct chains · 32% helix, 26% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Elongin-B | protein | 104 | 17% helix, 38% strand | Q15370 |
| B | Elongin-C | protein | 87 | 48% helix, 15% strand | Q15369 |
| C | Von hippel-lindau disease tumor suppressor | protein | 142 | 23% helix, 30% strand | P40337 |
| D, G, J | Elongin-B | protein | 103 | 15% helix, 37% strand | Q15370 |
| E | Elongin-C | protein | 91 | 46% helix, 14% strand | Q15369 |
| F, I, L | Von hippel-lindau disease tumor suppressor | protein | 143 | 25% helix, 31% strand | P40337 |
| H | Elongin-C | protein | 89 | 46% helix, 15% strand | Q15369 |
| K | Elongin-C | protein | 88 | 48% helix, 15% strand | Q15369 |
Ligands and binding sites
- 9BN · (2~{S},4~{R})-1-[(2~{S})-2-[(1-ethanoylcyclopropyl)carbonylamino]-3,3-dimethyl-butanoyl]-~{N}-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-4-oxidanyl-pyrrolidine-2-carboxamide · ligand · 4 copies · chains C, F, I, L
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
9 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 298 | 0.62 | 0.79 | 40 | 9BN |
| 2 | 272 | 0.61 | 0.79 | 39 | empty |
| 3 | 150 | 0.42 | 0.75 | 23 | empty |
| 4 | 151 | 0.41 | 0.74 | 22 | empty |
| 5 | 126 | 0.37 | 0.73 | 23 | empty |
Interfaces
18 interfaces between chains.
- G–H · 1140 Ų buried · 10 hydrogen bonds · protein-protein
- J–K · 1135 Ų buried · 13 hydrogen bonds · protein-protein
- D–E · 1128 Ų buried · 11 hydrogen bonds · protein-protein
- A–B · 1122 Ų buried · 12 hydrogen bonds · protein-protein
- E–F · 1054 Ų buried · 12 hydrogen bonds · protein-protein
Modifications
Observed in the structure: 12 modified (artifact).
Compared structures
- 5NVZ · pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(1-acetylcyclopropanecarboxamido)-3,3-dime… · the same entry in another collection · chain L against L, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q15370
- Every structure of UniProt Q15369
- Every structure of UniProt P40337
- Elsewhere: RCSB PDB 5NVZ · PDBe 5NVZ · UniProt Q15370 · UniProt Q15369 · UniProt P40337
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.